Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
MEDI
41
HOLDINGS
8%
ALSO IN OZEM
OZEM
21
HOLDINGS
14%
ALSO IN MEDI
SECTOR DRIFT (MEDI minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDI |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.7% | 18.2% | 18.2% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.8% | 1.5% | 1.5% |
 |
NOVO-NORDISK A/S-SPONS ADR | 1.2% | 13.1% | 1.2% |
MEDI Overweight Relative to OZEM
|
ASCENDIS PHARMA A/S | 15.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 5.2% |
|
ABBVIE INC | 4.7% |
|
VAXCYTE, INC. | 4.6% |
|
INTUITIVE SURGICAL INC | 4.5% |
|
INSMED INC | 3.6% |
|
ABIVAX SA-ADR | 3.5% |
|
ELI LILLY & CO | 2.5% |
|
DANAHER CORP | 2.4% |
|
NATERA INC | 2.4% |
MEDI Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -11.9% |
|
PFIZER INC | -6.4% |
|
VIKING THERAPEUTICS, INC. | -4.8% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.3% |
|
ZEALAND PHARMA A/S | -4.1% |
 |
HANMI PHARM CO LTD | -4.0% |
 |
INNOVENT BIOLOGICS, INC. | -4.0% |
|
AMGEN INC | -3.5% |
 |
ASCLETIS PHARMA, INC. | -3.3% |